Loading...

Ipsen S.A.

IPSEYPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$32.42
$-0.58(-1.76%)

Ipsen S.A. (IPSEY) Stock Overview

Explore Ipsen S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap42.9B
P/E Ratio53.58
EPS (TTM)$1.24
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 Week$30.45
1 Month$26.81
3 Months$29.92
1 Year Target$28.99

IPSEY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Ipsen S.A. (IPSEY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 75.48, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $28.99.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 53.58 and a market capitalization of 42.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;